Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Advantages of routine next generation sequencing over standard genetic testing in the ALS clinic.

Scaber J. et al, (2023), Eur J Neurol

Human iPSC co-culture model to investigate the interaction between microglia and motor neurons

Vahsen BF. et al, (2022), Scientific Reports, 12

A case of SOD1 deficiency: implications for clinical trials.

Farrimond L. and Talbot K., (2022), Brain

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

Thompson AG. et al, (2022), Brain Communications, 4

Impairment of mitochondrial calcium buffering links mutations in C9orf72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD

DAFINCA R. et al, (2020), Stem Cell Reports

Memantine for dementia.

McShane R. et al, (2019), Cochrane Database Syst Rev, 3

Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction

Gordon D. et al, (2019), Neurobiology of Disease, 121, 148 - 162

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis

Salter M. et al, (2018), EBioMedicine, 33, 169 - 184

TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca2+ signaling in motor neurons

Mutihac R. et al, (2015), Neurobiology of Disease, 75, 64 - 77

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review

Farrimond LE. et al, (2012), BMJ Open, 2, e000917 - e000917

Include forthcoming?